RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

LungPass (stethoscope)

Product
Developers: Healthy Networks
Date of the premiere of the system: December, 2020
Branches: Pharmaceutics, medicine, health care

2020: LungPass start - devices for diagnosis of diseases of lungs

In the middle of December, 2020 the Estonian company Healthy Networks released LungPass, Bluetooth stethoscope based on artificial intelligence. He is capable to analyze the sounds proceeding from lungs and to help to diagnose or control different respiratory diseases, including pneumonia and the chronic obstructive pulmonary disease (COPD).

The purpose consisted in creation of inexpensive technology (the device costs $105), which people could hold houses for detection of respiratory diseases or their control. Such approach could change outcomes of many diseases of lungs, such as pneumonia at which timely diagnostics and intervention are crucial.

The Estonian company released the LungPass device diagnosing diseases of lungs

The new device can significantly affect also chronic noninfectious diseases of lungs. The Chronic Obstructive Pulmonary Disease (COPD) annually claims the lives of 3.2 million people, and this disease develops at every fifth smoker. It is one of the most expensive diseases of which more than $35 billion in the USA and €20 billion in the EU are the share, and a considerable part of these expenses is connected with hospitalization. Now complete treatment at HOBL is impossible.

Besides, doctors have no objective tools which would allow people to monitor progressing of a disease with HOBL and in time to reveal aggravation or serious deterioration in symptoms. People are forced to rely on assessment of constantly present and constantly changing symptoms. As a result it leads to initially preventable hospitalization, decline in quality of life and growth of death rate.

LungPass can occupy a niche of objective tools for identification of aggravations of HOBL. It turns sounds of lungs into objective early biomarkers of diseases of lungs. Selecting every day only several minutes for survey, each patient will be able independently to control the status and to reveal deterioration in a respiratory disease, without leaving the house.[1]

Notes